The potential of antisense oligonucleotide therapies for inherited childhood lung diseases

Antisense oligonucleotides are an emerging therapeutic option to treat diseases with known genetic origin. In the age of personalised medicines, antisense oligonucleotides can sometimes be designed to target and bypass or overcome a patient’s genetic mutation, in particular those lesions that compro...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinovich, Kelly M., Shaw, Nicole C., Kicic, Anthony, Schultz, André, Fletcher, Sue, Wilton, Steve D., Stick, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801198/
https://www.ncbi.nlm.nih.gov/pubmed/29411170
http://dx.doi.org/10.1186/s40348-018-0081-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801198/
https://www.ncbi.nlm.nih.gov/pubmed/29411170
http://dx.doi.org/10.1186/s40348-018-0081-6

Ejemplares similares